Member Exclusive News

Novel complex identified as target for autoimmune diseases

Researchers have found that the interaction between BRISC and SHMT2 may be responsible for the overproduction of cytokines during an autoimmune response, leading to the development of new therapies for diseases, such as lupus, through targeting this complex.

Please sign in or register for FREE

No comments yet.